Connect Biopharma Holdings Limited Ordinary Shares (CNTB) Technical Analysis
$2.19
Market is closed - opens 7 PM, 20 May 2026
Insights
- CONNECT BIOPHARMA HOLDINGS L is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for CONNECT BIOPHARMA HOLDINGS L stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, CONNECT BIOPHARMA HOLDINGS L stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for CONNECT BIOPHARMA HOLDINGS L stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 43.38 | Neutral |
Stochastic | 25.58, 38.76 | Neutral |
Ultimate Oscillator | 42.4 | Neutral |
Stochastic Relative Strength Index | 47.01, 56.58 | Neutral |
Moving Average Convergence Divergence | -0.08, -0.09 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.44 | Sell |
20 | 2.48 | Sell |
50 | 2.72 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.46 | Sell |
20 | 2.52 | Sell |
50 | 2.61 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.48 | Sell |
20 | 2.55 | Sell |
50 | 2.85 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.42 | Buy |
20 | 2.4 | Sell |
50 | 2.57 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 2.44 | Buy |
20 | 2.38 | Sell |
50 | 2.46 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 2.77 |
Resistance L2 | 2.68 |
Resistance L1 | 2.58 |
Pivot Point | 2.49 |
Support L1 | 2.39 |
Support L2 | 2.3 |
Support L3 | 2.2 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.